Investigating how a specific RNA affects allergic responses
Long Non-Coding RNAs in Allergy
['FUNDING_R01'] · NORTHWESTERN UNIVERSITY AT CHICAGO · NIH-10688036
This study is looking at how a specific molecule called Morrbid affects immune cells involved in allergies, with the hope of finding new ways to treat allergic reactions.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NORTHWESTERN UNIVERSITY AT CHICAGO (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-10688036 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding the role of long non-coding RNA (lncRNA) Morrbid in controlling allergic responses, particularly in the differentiation of immune cells that contribute to allergies. By studying how Morrbid influences the generation of specific T helper cells, the research aims to uncover new therapeutic targets for managing allergic diseases. The approach includes advanced techniques like single-cell RNA sequencing to analyze immune cell behavior in detail. If successful, this research could lead to innovative strategies for treating allergies by manipulating immune responses.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with allergic conditions, particularly those experiencing severe allergic responses.
Not a fit: Patients with non-allergic conditions or those whose allergies are not driven by immune cell differentiation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide new treatment options for patients suffering from allergies by targeting specific immune pathways.
How similar studies have performed: Previous research has shown promise in manipulating immune responses through RNA mechanisms, suggesting potential for success in this novel approach.
Where this research is happening
CHICAGO, UNITED STATES
- NORTHWESTERN UNIVERSITY AT CHICAGO — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WILLIAMS, ADAM — NORTHWESTERN UNIVERSITY AT CHICAGO
- Study coordinator: WILLIAMS, ADAM
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Allergic Disease